[Federal Register Volume 89, Number 51 (Thursday, March 14, 2024)]
[Notices]
[Pages 18653-18655]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05444]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) will publish a summary of information 
collection requests under OMB review, in compliance with the Paperwork 
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these 
documents, call the SAMHSA Reports Clearance Officer on (240) 276-0361.

Proposed Project: New: The Center for Substance Abuse Prevention Online 
Reporting Tool and Grant Programmatic Progress Report To Replace 
Division of State Programs--Management Reporting Tool (DSP-MRT) (OMB 
No. 0930-0354)

    The Substance Abuse and Mental Health Services Administration's 
(SAMHSA), Center for Substance Abuse Prevention (CSAP) is requesting 
approval from the Office of Management and Budget (OMB) to monitor CSAP 
discretionary grant programs through administration of a suite of data 
collection instruments for grant compliance and programmatic 
performance monitoring. This package describes the data collection 
activities and proposed instruments. Grant compliance monitoring will 
be conducted via a single data collection instrument to be completed by 
all CSAP discretionary grant recipients. Programmatic performance 
monitoring will be conducted via a suite of data collection instruments 
with each instrument tailored to a specific CSAP discretionary program. 
This request for data collection will replace OMB No. 0930-0354: 
Division of State Programs--Management Reporting Tool.
    CSAP intends to monitor six grant programs through this data 
collection effort:
     Strategic Prevention Framework--Partnerships for Success 
(SPF-PFS): The purpose of the SPF-PFS program is to help reduce the 
onset and progression of substance misuse and its related problems by 
supporting the development and delivery of state and community 
substance misuse prevention and mental health promotion services. This 
program is intended to promote substance use prevention throughout a 
state jurisdiction for individuals and families by building and 
expanding the capacity of local community prevention providers to 
implement evidence-based programs. In addition, the program is intended 
to expand and strengthen the capacity of local community prevention 
providers to implement evidence-based prevention programs. With this 
program, SAMHSA aims to strengthen state and community level prevention 
capacity to identify and address local substance use prevention 
concerns, such as underage drinking, marijuana, tobacco, electronic 
cigarettes, opioids, methamphetamine, and heroin.
     Sober Truth on Preventing Underage Drinking (STOP Act): 
The purpose of this program is to prevent and reduce alcohol use among 
youth and young adults ages 12-20 in communities throughout the United 
States through evidence-based screening, programs and curricula, brief 
intervention strategies, consistent policy enforcement, and 
environmental changes that limit underage access to alcohol as 
authorized by 942 U.S.C. 290bb-25b. The program aims to: (1) address 
norms regarding alcohol use by youth, (2) reduce opportunities for 
underage drinking, (3) create changes in underage drinking enforcement 
efforts, (4) address penalties for underage use, and/or (5) reduce 
negative consequences associated with underage drinking.
     Strategic Prevention Framework for Prescription Drugs (SPF 
Rx): The purpose of the SPF Rx grant program is to provide resources to 
help prevent and address prescription drug misuse within a State or 
locality. The program is designed to raise awareness about the dangers 
of sharing medications as well as the risks of fake or counterfeit 
pills purchased over social media or other unknown sources, and work 
with pharmaceutical and medical communities on the risks of 
overprescribing. Whether addressed at the state level or by an informed 
community-based organization, the SPF Rx program will raise community 
awareness and bring prescription substance misuse prevention activities 
and education to schools, communities, parents, prescribers, and their 
patients. In addition, grant recipients will be required to track 
reductions in opioid related overdoses and incorporate relevant 
prescription and overdose data into strategic planning and future 
programming.
     First Responders--Comprehensive Addiction and Recovery Act 
(FR CARA): The purpose of this program is to allow first responders and 
members of other key community sectors to administer a drug or device 
approved or cleared under the Federal Food, Drug, and Cosmetic Act for 
emergency treatment of known or suspected opioid overdose.
     Grants to Prevent Prescription Drug/Opioid Overdose-
Related Deaths (PDO): The purpose of this program is to support first 
responders and members of other key community sectors to administer a 
drug or device approved or cleared under the Federal Food, Drug, and 
Cosmetic Act (FD&C Act) for emergency reversal of known or suspected 
opioid overdose. Recipients will train and provide resources to first 
responders and members of other key community sectors at the state, 
tribal, and local levels on carrying and administering a drug or device 
approved or cleared under the FD&C Act for emergency treatment of known 
or suspected opioid overdose.
     Improving Access to Overdose Treatment (ODTA): The purpose 
of this program is to expand access to naloxone and other Food and Drug 
Administration (FDA) approved overdose reversal medications for 
emergency treatment of known or suspected opioid overdose. The 
recipients will collaborate with other prescribers at the community 
level to implement trainings on policies, procedures, and models of 
care for prescribing, co-prescribing, and expanding access to naloxone 
and other FDA-approved overdose reversal medications to the specified 
population of focus (i.e., rural or urban). With this program SAMHSA 
aims to expand access to naloxone and other FDA approved overdose 
reversal medications for emergency treatment of known or suspected 
opioid overdose.
    Grant compliance monitoring: All SAMHSA awards require grantees to 
submit performance and progress reports through the electronic Research

[[Page 18654]]

Administration (eRA) Commons, an end-to-end Grants Management system. 
The frequency and program-specific instructions for preparation and 
submission of these reports are identified in the terms and conditions 
found in the Notice of Award. CSAP discretionary grant compliance 
monitoring will be conducted through the submission of the Programmatic 
Progress Report (PPR). The PPR contains fields for grantees to enter 
information on activities and accomplishments that occurred during the 
reporting period based on identified goals and objectives. It also 
contains fields for grantees to share evaluation updates and outcomes 
as well as planned activities for the upcoming reporting period as well 
as any challenges that grantees have experienced.
    The Center for Substance Abuse Prevention Online Reporting Tool 
(CORT) is comprised of two components. The first provides fields for 
grantees to enter annual goals for key programmatic measures. The 
second provides fields for reporting quarterly progress toward 
achieving these goals. CSAP intends to have grantees report progress on 
a quarterly basis to allow for consistent, periodic analyses which will 
allow for the administration of technical assistance supports when 
grantees are falling behind in achieving these goals. Quarterly 
reporting will also allow the Center to review the overall progress of 
grant programs. Program specific instruments have been developed to 
ensure optimal alignment with individual grant requirements. These 
instruments were developed based on instruments approved in OMB 0930-
0391: Harm Reduction Grant Program Annual Targets and Quarterly 
Progress Reports.

Annualized Data Collection Burden

                                                Table 1--Burden Table: Annualized Burden--Annual Targets
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                  Total                  Total     Average      Total
                          Instrument                              Number of    Responses per    number of   Hours per    burden     hourly    respondent
                                                                 respondents     respondent     responses   response     hours     wage\1\       cost
--------------------------------------------------------------------------------------------------------------------------------------------------------
STOP Act......................................................           202                1         202         0.5        101     $48.35    $4,883.35
SPF-PFS.......................................................           315                1         315         0.5      157.5      48.35    7,615.125
FR CARA.......................................................            87                1          87         0.5       43.5      48.35    2,103.225
PDO...........................................................            18                1          18         0.5          9      48.35       435.15
ODTA..........................................................             8                1           8         0.5          4      48.35        193.4
SPF-Rx........................................................            27                1          27         0.5       13.5      48.35      652.725
                                                               -----------------------------------------------------------------------------------------
    Total (Annual)............................................           657  ...............         657  ..........      328.5  .........    15,882.98
--------------------------------------------------------------------------------------------------------------------------------------------------------


            Table 2--Burden Table: Center for Substance Abuse Prevention On-Line Report Tool (CORT)--Quarterly Performance Annualized Burden
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                  Total                  Total     Average      Total
                          Instrument                              Number of    Responses per    number of   Hours per    burden     hourly    respondent
                                                                 respondents     respondent     responses   response     hours     wage \1\      cost
--------------------------------------------------------------------------------------------------------------------------------------------------------
STOP Act......................................................           202                4         808         0.5        404     $48.35   $19,533.40
SPF-PFS.......................................................           315                4       1,260         0.5        630      48.35    30,460.50
FR CARA.......................................................            87                4         348         0.5        174      48.35     8,412.90
PDO...........................................................            18                4          72         0.5         36      48.35     1,740.60
ODTA..........................................................             8                4          32         0.5         16      48.35       773.60
SPF-Rx........................................................            27                4         108         0.5         54      48.35     2,610.90
                                                               -----------------------------------------------------------------------------------------
    Total (Annual)............................................           657  ...............       2,628  ..........      1,314  .........    63,531.90
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ Grantee Project Director or Evaluator hourly wage is based on the mean hourly wage for state government managers, as reported in the 2022
  Occupational Employment (OES) by the Bureau of Labor Statistics (BLS) found at https://www.bls.gov/oes/current/naics4_999200.htm#11-0000 Accessed on
  December 13, 2023.


                                       Table 3--Annualized Burden Table: CSAP's Grant Programmatic Progress Report
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                  Total                  Total     Average      Total
                      CSAP grant program                          Number of    Responses per    number of   Hours per    burden     hourly    respondent
                                                                 respondents     respondent     responses   response     hours     wage \1\      cost
--------------------------------------------------------------------------------------------------------------------------------------------------------
SPF-PFS.......................................................           315                1         315           3      945.0     $48.35   $45,690.75
STOP Act......................................................           202                1         202           3      606.0      48.35    29,300.10
SPF Rx........................................................            27                1          27           3       81.0      48.35     3,916.35
FR CARA.......................................................            87                1          87           3      261.0      48.35    12,619.35
PDO...........................................................            18                1          18           3       54.0      48.35     2,610.90
ODTA..........................................................             8                1           8           3       24.0      48.35     1,160.40
                                                               -----------------------------------------------------------------------------------------
    Total (Annual)............................................           657  ...............  ..........  ..........   1,971.00  .........    95,297.85
--------------------------------------------------------------------------------------------------------------------------------------------------------


[[Page 18655]]

    Send comments to Carlos Graham, SAMHSA Reports Clearance Officer, 
5600 Fisher Lane, Room 15E57A, Rockville, MD 20852 OR email him a copy 
at [email protected]. Written comments should be received by 
May 13, 2024.

Alicia Broadus,
Public Health Advisor.
[FR Doc. 2024-05444 Filed 3-13-24; 8:45 am]
BILLING CODE 4162-20-P